1. Academic Validation
  2. Self-assembled hyaluronic acid nanoparticles for osteoarthritis treatment

Self-assembled hyaluronic acid nanoparticles for osteoarthritis treatment

  • Biomaterials. 2021 Aug:275:120967. doi: 10.1016/j.biomaterials.2021.120967.
Li-Jung Kang 1 Juhwan Yoon 2 Jun Gi Rho 3 Hwa Seung Han 4 Seulbi Lee 2 Young Soo Oh 5 Hwan Kim 6 Eunha Kim 2 Seok Jung Kim 7 Yong Taik Lim 8 Jae Hyung Park 9 Woo Keun Song 5 Siyoung Yang 10 Wook Kim 11
Affiliations

Affiliations

  • 1 Department of Pharmacology, Ajou University School of Medicine, Suwon, 16499, Republic of Korea; Degenerative InterDiseases Research Center, Ajou University School of Medicine, Suwon, 16499, Republic of Korea; CIRNO, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  • 2 Department of Molecular Science & Technology, Ajou University, Suwon, 16499, Republic of Korea.
  • 3 Department of Molecular Science & Technology, Ajou University, Suwon, 16499, Republic of Korea; Pharmaceutical Institute, FromBIO, Suwon, 16681, Republic of Korea.
  • 4 School of Chemical Engineering, Sungkyunkwan University, Suwon, 16419, Republic of Korea; Natural Product Informatics Research Center, Korea Institute of Science and Technology (KIST), Gangneung, 25451, Republic of Korea.
  • 5 Cell Logistics Research Center, School of Life Science, Gwangju Institute of Science and Technology, Gwangju, 61005, Republic of Korea.
  • 6 GIST Central Research Facilities, Bio Imaging Laboratory, Gwangju Institute of Science and Technology, Gwangju, 61005, Republic of Korea.
  • 7 Department of Orthopaedic Surgery, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • 8 CIRNO, Sungkyunkwan University, Suwon, 16419, Republic of Korea; School of Chemical Engineering, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  • 9 School of Chemical Engineering, Sungkyunkwan University, Suwon, 16419, Republic of Korea; Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  • 10 Department of Pharmacology, Ajou University School of Medicine, Suwon, 16499, Republic of Korea; Degenerative InterDiseases Research Center, Ajou University School of Medicine, Suwon, 16499, Republic of Korea; CIRNO, Sungkyunkwan University, Suwon, 16419, Republic of Korea. Electronic address: [email protected].
  • 11 Department of Molecular Science & Technology, Ajou University, Suwon, 16499, Republic of Korea. Electronic address: [email protected].
Abstract

Although osteoarthritis (OA) is the most prevalent degenerative joint disease, there is no effective disease-modifying therapy. We report an empty self-assembled hyaluronic acid nanoparticle (HA-NP) as a potential therapeutic agent for OA treatment. In mouse primary articular chondrocytes, HA-NPs blocked the receptor-mediated cellular uptake of free low-molecular-weight HA, and the cellular uptake of HA-NPs increased by ectopic expression of CD44, using an adenoviral delivery system (Ad-Cd44). HA-NP showed in vitro resistance to digestion with hyaluronidase and in vivo long-term retention ability in knee joint, compared with free high-molecular-weight (HMW) HA. CD44 expression increased in the damaged articular cartilage of patients and mice with OA. Ad-Cd44 Infection and IL-1β treatment induced in vitro phenotypes of OA by enhancing catabolic gene expression in primary articular chondrocytes, and these effects were attenuated by HA-NP, but not HMW HA. Both CD44 deficiency and intra-articular injection of HA-NP protected joint cartilage against OA development in the OA mouse model. NF-κB was found to mediate CD44-induced catabolic factor expression and HA-NP inhibited CD44-induced NF-κB activation in chondrocytes. Our results identify an empty HA-NP as a potential therapeutic agent targeting CD44 for OA treatment, and the CD44-NF-κB-catabolic gene axis as an underlying mechanism of destructive cartilage disorders.

Keywords

CD44; Catabolic factor; Hyaluronic acid; Osteoarthritis; Self-assembled nanoparticle.

Figures
Products